've made the point before that money is in a way simply Representative of ideas in motion - just as are goods and services.
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
arget="_new">Zazzle.com and
Cafepress.com are two examples of new, consumer-creator driven media - th
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
antithesis of top-down marketing models. They are viral, marketed between friends and among interest groups and can be intensely topical. There's no inve
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
stment barrier. I create artwork or write words, and I "sell" those images and words. The company merely puts the images on the chosen media, and they mak
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
their money on that.
They are both making MORE money by realizing that they do not have to shape the tastes and opinions of their consumers. And as I st
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
ated in Jump on the Cluetrain - that means people are the new brands.
Michelle is a brand. I am a brand. Tacitus and Dkos are brands.
But the traditiona
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
brands - for peas and pajamas and politics - those are in deep, deep trouble.
The vast uncommitted center in the upcoming election will not be voting fo
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
r a republican or a democrat. They will be voting for either the George Bush brand or the John Kerry brand - neither of which bears a great resemblance to
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
the traditional, bland and homogeneous image of their respective parties.
And it's worth checking out how people are playing on those brands:
Anti Bush
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
activists are vitriolic.
Pro Kerry can be summed up as "being praised with faint damns."
Pro Bush is almost all anti-bush, with a few genuine items that
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
prove that those few that are for bush and are on Cafepress are somewhat conventional-minded, humor-impaired, or just plain freaky-nuts.
I'm interpreting
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
this as being simply that social conservatives view this sort of venue as sheer anarchist chaos with no focused central message.
And it is an antiathori
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
arian venue for sure, because (with certain vague and tiny limitations), you can say whatever the hell you like on a Cafepress product, and benefit by it
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
- or not. The market determines if anyone gives a damn about your "brand" of speech.
As Papa Heinlein observed; "Money is the sincerest form of applause.
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products